The CDC reports that COVID-19 infections are growing or likely growing in 37 states, including Ohio. COVID-19 hospitalizations in Ohio more than doubled from early to late December, coinciding with ...
It has been almost six years since the World Health Organization declared COVID-19 a pandemic in 2020, and while it is no longer considered a public health emergency, it can still make more vulnerable ...
COVID-19 infections are rising across the United States, amid surges in other winter illnesses. The uptick in COVID comes as the country faces a severe flu season and outbreaks of norovirus, which are ...
The Stratus variant is fueling COVID-19 cases around the country. Symptoms of the virus look slightly different right now. Here, doctors share what to look out for and how to protect yourself from the ...
Covid-19 vaccines, credited with saving millions of lives during the pandemic, set off a powerful alarm that rallies the human immune system against cancer and nearly doubles the median survival ...
Many people are running into confusion this season when trying to get a COVID-19 vaccine. That’s because federal guidance changed this fall: vaccine advisers to the U.S. Centers for Disease Control ...
The federal government program that mailed free at-home COVID-19 tests to households is no longer active. Some insurance providers may still cover the cost of at-home tests, and free tests may be ...
The federal government program that mailed free at-home COVID-19 tests to households is no longer active. Some insurance providers may still cover the cost of at-home tests, and free tests may be ...
Kaiser Permanente is preparing its rollout of the new COVID-19 vaccine regardless of federal guidelines that limit who should get the shots.The health care provider said it is making its new vaccine ...
The U.S. death rate has dropped to prepandemic levels as COVID-19 fell out of the top 10 leading causes of death, according to research published Wednesday. The death rate fell by 3.8 percent in 2024, ...
The updated mRNA vaccines target the LP.8.1 variant of SARS-CoV-2. The Food and Drug Administration (FDA) has approved the 2025-2026 formulations of Moderna’s COVID-19 vaccines Spikevax ® and ...